Spiration designed and manufactured innovative thoracic and intrabronchial medical devices for the treatment of lung disease, including chronic obstructive pulmonary disease (COPD), specifically emphysema. Spiration was acquired by Olympus Medical Systems in 2010.
Labrys Biologics is a private, venture-financed development stage biotechnology company focused on treatments for chronic migraine. Labrys' lead candidate, LBR-101 (formerly known as RN-307), is an anti-CGRP monoclonal antibody which has completed Phase 1.
Welltok is pioneering Health Optimization by revolutionizing the way population managers - payers, ACOs and health systems - guide and incentivize consumer health. Its groundbreaking CaféWell Health Optimization Platform drives engagement and improves healthcare value by aligning rewards and incentives with activities and programs.